More recently, it has been reported that the reduced expression of NCOR2 increases PRAD progression and shorter disease-free survival and accelerates disease progression following androgen deprivation, suggesting a more direct role to regulate the AR [63]. This evidence concerns the gene NCOR2 and prostate adenocarcinoma.